icon-folder.gif   Conference Reports for NATAP  
 
  EASL 48th Annual Meeting
April 24th - 28th 2013
The Netherlands, Amsterdam
Back grey_arrow_rt.gif
 
 
 
ELECTRON: All-Oral Sofosbuvir-Based 12-Week Regimens for the Treatment of Chronic HCV GT 1 Infection
 
 
  Reported by Jules Levin
EASL 2013 Amsterdam April 25
 
Edward J. Gane1, Catherine A. Stedman2, Robert H. Hyland3, Xiao Ding3, Phillip S. Pang3, William T. Symonds3, John G. McHutchison3
1Auckland Clinical Studies, Auckland, New Zealand; 2Christchurch Clinical Studies Trust, Christchurch, New Zealand; 3Gilead Sciences, Inc., Foster City, CA, USA

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif

EASL9.gif

EASL10.gif

EASL11.gif